Hyperbaric Oxygen Therapy (HBOT)
& Mild Hyperbaric Oxygen Therapy (mHBOT)Hyperbaric oxygen therapy (HBOT) refers to intermittent treatment of the entire body with 100-percent oxygen at greater than normal atmospheric pressures. Mild Hyperbarics (mHBOT) uses increased air pressure (instead of pure oxygen) to deliver additional oxygen to the bloodstream and tissues. Hyperbaric therapy is increasingly being used to realize benefits in children with Autism spectrum disorders because of its ability to deliver greater oxygen levels to the brain and vital organs and stimulate tissue regeneration. With autistics, hyperbaric oxygen therapy treatment has been known to improve verbal communication, direct eye contact, reasoning ability, motor skills, balance, attention and reduce aggressive behavior.
To access the video clips, click the links beneath the Quicktime or Windows Media format icons for either the "Low" bandwidth (dial-up connection) or "High" bandwidth (DSL or Broadband) sizes.
All video clips are the copyright of the Foundation for Autism Information and Research (F.A.I.R. Autism Media) and are intended for informational purposes only. The content herein is not intended as medical advice.
You will need Windows Media Player, or Quicktime Player to view these clips.
––––––––––––––––––––––––––––––––––––––––––––––––––––
Dr. Dan Rossignol
Dr. Dan Rossignol received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia (UVa). He is a former clinical assistant professor of family medicine at UVa and is currently a staff physician at the International Child Development Resource Center in Melbourne, FL. One of his clinical interests is the use of hyperbaric oxygen therapy (HBOT) in neurodevelopment disorders, including autism. He has authored several papers on the use of HBOT in autism and other conditions. He has spoken many times on the use of HBOT in individuals with autism, and is actively involved in research on HBOT, metal toxicity, and nutritional treatments for autism and other neurological conditions.
Download
Dr. James Neubrander
Dr. James Neubrander is board certified in Environmental Medicine with special interests in heavy metals, folate/B12 biochemistry, hyperbaric oxygen therapy and QEEG. He practices in Edison, NJ where he dedicates 95% of his time to patients seeking the biomedical approach to autistic spectrum disorders. He is the originator of the use of injectable methylcobalamin, and since 2002, he has monitored between one-half million to one million doses of methyl-B12 in his clinic for children on the autistic spectrum. He has also documented the benefits seen in over 25,000 to 30,000 hours of hyperbaric oxygen therapy treatment for children with neurodevelopmental disorders. As a member of the Scientific Advisory Committee of the International Brain Research Foundation, he is currently involved in several clinical and scientific studies with various leaders in the field who deal with neurodevelomental and neurocognitive disorders with children and adults on the autistic spectrum.
Visit Midwest Hyperbarics Institute's website for more information.
Dr. August Martinucci
Dr. August Martinucci is the Medical Director for the Midwest Hyperbarics Institute, P.C. located in Bolingbrook, Illinois. In this interview, Dr. Martinucci discusses hyperbaric oxygen therapy and its uses for children with autism spectrum disorders.
Visit International Hyperbarics Association's website for more information.
Shannon Kenitz
Degreed in psychology, Shannon Kenitz is the Executive Director of the International Hyperbarics Association, a non-profit organization that promotes Hyperbaric Therapy through education and research. Shannon Kenitz knows firsthand the heartbreak and struggles of having a child with a disability. Her youngest daughter, Grace, was diagnosed with a very rare mitochondrial disorder that kept her in the hospital virtually for the first three years of her life. Grace more recently has been diagnosed on the autism spectrum. Shannon did not accept the recommendation to cease life-prolonging measures. And because of that, Grace progressed to feed herself, recover from blindness, and at almost 7-years old, walk for the first time on January 20, 2006. Shannon has interviewed for the Montel Williams show and has a book and movie forthcoming.
